4TEEN4 Pharmaceuticals GmbH announced that it has entered into equity investment on February 21, 2024. The transaction included participation from new investor, Boditech Med Inc. The investor has acquired 3.03% stake in the company.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17,170 KRW | -1.89% | -2.72% | -16.24% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.24% | 27Cr | |
-26.77% | 1.65TCr | |
-43.46% | 279.07Cr | |
+22.46% | 193.77Cr | |
-12.32% | 146.05Cr | |
+31.49% | 133.45Cr | |
-16.15% | 97Cr | |
+1.33% | 79Cr | |
-31.07% | 79Cr | |
-25.95% | 62Cr |
- Stock Market
- Equities
- A206640 Stock
- News Boditech Med Inc.
- 4TEEN4 Pharmaceuticals GmbH announced that it has received funding from Boditech Med Inc.